MedTrace Logo

Treatment Decision-making in Patients With Recurrent High-grade Glioma

NCT04013828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2022-04-20

No results posted yet for this study

Summary

This qualitative study explores the lived experience of high-grade glioma patients and their close relatives at time of recurrence. With focus on the decision-making about treatment and care..

Conditions

  • Malignant Glioma
  • Life Experiences

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Region of Southern Denmark

    collaborator OTHER

  • Danish Cancer Society

    collaborator OTHER

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Frantz Rom Poulsen, Professor · Department of Neurosurgery Odense University Hospital DK-5000 Odense C DENMARK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-06
Primary Completion
2020-04-03
Completion
2022-04-08

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013828 on ClinicalTrials.gov